- Home
- ABP vs ADXN Comparison
ABP vs ADXN Comparison
Compare ABP & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABP
- ADXN
- Stock Information
- Founded
- ABP 2004
- ADXN 2002
- Country
- ABP United States
- ADXN Switzerland
- Employees
- ABP N/A
- ADXN N/A
- Industry
- ABP Biotechnology: Pharmaceutical Preparations
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- ABP Health Care
- ADXN Health Care
- Exchange
- ABP Nasdaq
- ADXN Nasdaq
- Market Cap
- ABP 12.3M
- ADXN 10.1M
- IPO Year
- ABP N/A
- ADXN N/A
- Fundamental
- Price
- ABP $0.32
- ADXN $8.57
- Analyst Decision
- ABP Strong Buy
- ADXN Strong Buy
- Analyst Count
- ABP 1
- ADXN 1
- Target Price
- ABP $4.00
- ADXN $30.00
- AVG Volume (30 Days)
- ABP 15.4M
- ADXN 11.8K
- Earning Date
- ABP 08-18-2025
- ADXN 08-11-2025
- Dividend Yield
- ABP N/A
- ADXN N/A
- EPS Growth
- ABP N/A
- ADXN N/A
- EPS
- ABP N/A
- ADXN 0.10
- Revenue
- ABP $183,000.00
- ADXN $278,508.00
- Revenue This Year
- ABP N/A
- ADXN $86.57
- Revenue Next Year
- ABP N/A
- ADXN N/A
- P/E Ratio
- ABP N/A
- ADXN $0.75
- Revenue Growth
- ABP 88.66
- ADXN N/A
- 52 Week Low
- ABP $0.15
- ADXN $6.51
- 52 Week High
- ABP $11.19
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- ABP N/A
- ADXN 49.52
- Support Level
- ABP N/A
- ADXN $7.52
- Resistance Level
- ABP N/A
- ADXN $8.71
- Average True Range (ATR)
- ABP 0.00
- ADXN 0.34
- MACD
- ABP 0.00
- ADXN -0.08
- Stochastic Oscillator
- ABP 0.00
- ADXN 53.48
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.